Oncology approvals in 2020: a year of firsts in the midst of a pandemic

por Amiri-Kordestani, Laleh, Pazdur, Richard
Publicado 2021

To Adjudicate or Not Adjudicate: That Is the Question

por Hicks, Karen A., Fashoyin-Aje, Lola A., Amiri-Kordestani, Laleh
Publicado 2022

Patient‐Friendly Language to Facilitate Treatment Choice for Patients with Cancer

por Kim, Janice, Gao, Jennifer, Amiri‐Kordestani, Laleh, Beaver, Julia A., Kluetz, Paul
Publicado 2019

Novel SIL1 mutations in consanguineous Pakistani families mapping to chromosomes 5q31

por Riazuddin, S. Amer, Amiri-Kordestani, Laleh, Kaul, Haiba, Butt, Tariq, Jiao, Xiaodong, Riazuddin, Sheikh, Hejtmancik, J. Fielding
Publicado 2009

Assessing cardiac safety in oncology drug development

por Seltzer, Jonathan H, Gintant, Gary, Amiri-Kordestani, Laleh, Singer, Jack, Koplowitz, Luana Pesco, Moslehi, Javid J, Barac, Ana, Yu, Anthony F.
Publicado 2019

21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine

por Sheng, Calvin Chen, Amiri-Kordestani, Laleh, Palmby, Todd, Force, Thomas, Hong, Charles C., Wu, Joseph C., Croce, Kevin, Kim, Geoffrey, Moslehi, Javid
Publicado 2016

Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action

por Neilan, Tomas G., Rothenberg, Mace L., Amiri‐Kordestani, Laleh, Sullivan, Ryan J., Steingart, Richard M., Gregory, William, Hariharan, Subramanian, Hammad, Tarek A., Lindenfeld, JoAnn, Murphy, Martin J., Moslehi, Javid J.
Publicado 2018

US Food and Drug Administration regulatory updates in neuro-oncology

por Mehta, Gautam U., Barone, Amy K., Bradford, Diana, Larkins, Erin, Kim, Janice, Pai-Scherf, Lee, Jaigirdar, Adnan, Shah, Mirat, Wedam, Suparna, Amiri-Kordestani, Laleh, Theoret, Marc R., Pazdur, Richard, Beaver, Julia A., Singh, Harpreet
Publicado 2021

Systematic Review of PD‐1/PD‐L1 Inhibitors in Oncology: From Personalized Medicine to Public Health

por Chang, Elaine, Pelosof, Lorraine, Lemery, Steven, Gong, Yutao, Goldberg, Kirsten B., Farrell, Ann T., Keegan, Patricia, Veeraraghavan, Janaki, Wei, Guo, Blumenthal, Gideon M., Amiri‐Kordestani, Laleh, Singh, Harpreet, Fashoyin‐Aje, Lola, Gormley, Nicole, Kluetz, Paul G., Pazdur, Richard, Beaver, Julia A., Theoret, Marc R.
Publicado 2021

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

por Litton, Jennifer K., Regan, Meredith M., Pusztai, Lajos, Rugo, Hope S., Tolaney, Sara M., Garrett-Mayer, Elizabeth, Amiri-Kordestani, Laleh, Basho, Reva K., Best, Ana F., Boileau, Jean-Francois, Denkert, Carsten, Foster, Jared C., Harbeck, Nadia, Jacene, Heather A., King, Tari A., Mason, Ginny, O'Sullivan, Ciara C., Prowell, Tatiana M., Richardson, Andrea L., Sepulveda, Karla A., Smith, Mary Lou, Tjoe, Judy A., Turashvili, Gulisa, Woodward, Wendy A., Butler, Lynn Pearson, Schwartz, Elena I., Korde, Larissa A.
Publicado 2023